Antonarakis S E
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
N Engl J Med. 1989 Jan 19;320(3):153-63. doi: 10.1056/NEJM198901193200305.
In the past 10 years considerable progress has been made in the diagnosis of hereditary disorders at the DNA level. Many monogenic disorders can now be examined at the gene level; such examination has led to a better understanding of the molecular basis of these disorders and made carrier detection and prenatal diagnosis possible. Each year, more and more monogenic disorders can be added to the list of diseases that can be diagnosed by DNA analysis. Future research will be devoted to the identification of genes responsible for other known monogenic hereditary disorders, the elucidation of the molecular lesion associated with chromosomal abnormalities, and the characterization of the genes and gene defects involved in the common multifactorial diseases. The goal of diagnosis is the identification of the genetic defect in affected patients, persons destined to be affected, and carriers.
在过去十年中,在DNA水平上对遗传性疾病的诊断取得了相当大的进展。现在许多单基因疾病可以在基因水平上进行检测;这种检测使人们对这些疾病的分子基础有了更好的理解,并使携带者检测和产前诊断成为可能。每年,越来越多的单基因疾病可以被添加到可通过DNA分析诊断的疾病列表中。未来的研究将致力于确定导致其他已知单基因遗传性疾病的基因,阐明与染色体异常相关的分子病变,以及确定常见多因素疾病中涉及的基因和基因缺陷的特征。诊断的目标是识别受影响患者、注定要受影响的人以及携带者中的基因缺陷。